Gene · 5268
Papers2,479
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
141 to 160 of 2,479
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| Isomers Recognition in HPLC-MS/MS Analysis of Human Plasma Samples by Using an Ion Trap Supported by a Linear Equations-Based Algorithm. | Int J Mol Sci | 2023 | 37446333 | PubTator, text mining | PubMed |
| Diagnostic, Prognostic, and Therapeutic Role for Angiogenesis Markers in Head and Neck Squamous Cell Carcinoma: A Narrative Review. | Int J Mol Sci | 2023 | 37445908 | PubTator, text mining | PubMed |
| Analysis of the Mutational Landscape of Osteosarcomas Identifies Genes Related to Metastasis and Prognosis and Disrupted Biological Pathways of Immune Response and Bone Development. | Int J Mol Sci | 2023 | 37445641 | PubTator, text mining | PubMed |
| SERPINB5 is a prognostic biomarker and promotes proliferation, metastasis and epithelial-mesenchymal transition (EMT) in lung adenocarcinoma. | Thorac Cancer | 2023 | 37424293 | PubTator, text mining | PubMed |
| The SMAD2/miR-4256/HDAC5/p16INK4a signaling axis contributes to gastric cancer progression. | Oncol Res | 2023 | 37415735 | PubTator, text mining | PubMed |
| [Retracted] Celastrus orbiculatus extracts induce apoptosis and inhibit invasion by targeting the maspin gene in human gastric adenocarcinoma cells. | Oncol Lett | 2023 | 37415636 | PubTator, text mining | PubMed |
| CRIP1 Reshapes the Gastric Cancer Microenvironment to Facilitate Development of Lymphatic Metastasis. | Adv Sci (Weinh) | 2023 | 37409440 | PubTator, text mining | PubMed |
| Tumor budding as a potential prognostic marker in determining the behavior of primary liver cancers. | World J Hepatol | 2023 | 37397937 | PubTator, text mining | PubMed |
| Deciphering Stromal Changes between Metastatic and Non-metastatic Canine Mammary Carcinomas. | J Mammary Gland Biol Neoplasia | 2023 | 37391533 | PubTator, text mining | PubMed |
| RETRACTED: Expression of microRNAs and their target genes in melanomas originating from gynecologic sites. | PLoS One | 2023 | 37384650 | PubTator, text mining | PubMed |
| Intrinsic Immunogenic Tumor Cell Death Subtypes Delineate Prognosis and Responsiveness to Immunotherapy in Lung Adenocarcinoma. | Biology (Basel) | 2023 | 37372093 | PubTator, text mining | PubMed |
| PDE4DIP contributes to colorectal cancer growth and chemoresistance through modulation of the NF1/RAS signaling axis. | Cell Death Dis | 2023 | 37355626 | PubTator, text mining | PubMed |
| Effect of Maspin Gene Methylation Induced by Specific shRNA Sequences on the Proliferation of Oral Squamous Cell Carcinoma HN13 Cells. | Cell Mol Biol (Noisy-le-grand) | 2023 | 37329546 | PubTator, text mining | PubMed |
| Signet-Ring Cell Squamous Cell Carcinoma: A Biphenotypic Neoplasm of the Gastro-Esophageal Junction with Uncertain Biological Potential: Case Report and Literature Review. | Int J Mol Sci | 2023 | 37298485 | PubTator, text mining | PubMed |
| Minimally Invasive and Fast Diagnosis of Gastric Cancer Based on Maspin Levels in Different Biological Samples. | Diagnostics (Basel) | 2023 | 37296710 | PubTator, text mining | PubMed |
| Analysis of a large cohort of pancreatic cancer transcriptomic profiles to reveal the strongest prognostic factors. | Clin Transl Sci | 2023 | 37260110 | PubTator, text mining | PubMed |
| Development of the prognostic value in lung adenocarcinoma based on anoikis-related genes and initial experimental validation. | J Gene Med | 2023 | 37259225 | PubTator, text mining | PubMed |
| Getting the chronological age out of DNA: using insights of age-dependent DNA methylation for forensic DNA applications. | Genes Genomics | 2023 | 37253906 | PubTator, text mining | PubMed |
| Crosstalk between long noncoding RNA and microRNA in Cancer. | Cell Oncol (Dordr) | 2023 | 37245177 | PubTator, text mining | PubMed |
| Uptake-Dependent and -Independent Effects of Fibroblasts-Derived Extracellular Vesicles on Bone Marrow Endothelial Cells from Patients with Multiple Myeloma: Therapeutic and Clinical Implications. | Biomedicines | 2023 | 37239071 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/5268/papers?page=8